Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2019 Filed May 31, 2019 20:21 UTC |
INGRAM ROBERT ALEXANDERDirector
|
GrantAutomatic Stock Option Grant · Derivative | 30,000 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0001127602-19-020312 · form4.xml · derivative · entry 1 INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-05-29 F1 · security: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan. Read SEC document |
| May 29, 2019 Filed May 31, 2019 20:19 UTC |
Hutson Nancy JDirector
|
GrantAutomatic Stock Option Grant · Derivative | 30,000 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0001127602-19-020310 · form4.xml · derivative · entry 1 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-05-29 F1 · security: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan. Read SEC document |
| May 29, 2019 Filed May 31, 2019 20:16 UTC |
HEGGIE THERESADirector
|
GrantAutomatic Stock Option Grant · Derivative | 30,000 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0001127602-19-020306 · form4.xml · derivative · entry 1 HEGGIE THERESA · CIK 0001760020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-05-29 F1 · security: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan. Read SEC document |
| May 29, 2019 Filed May 31, 2019 20:10 UTC |
ABERCROMBIE GEORGE BDirector
|
GrantAutomatic Stock Option Grant · Derivative | 30,000 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0001127602-19-020298 · form4.xml · derivative · entry 1 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-05-29 F1 · security: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan. Read SEC document |
| May 22, 2019 Filed May 24, 2019 20:20 UTC |
ASELAGE STEVEDirector
|
PurchaseCommon Stock | 3,000 | $3.57 | $10,710.00 |
DisclosureSEC source: 0001127602-19-019891 · form4.xml · nonDerivative · entry 1 ASELAGE STEVE · CIK 0001221599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| May 17, 2019 Filed May 20, 2019 20:21 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 2,500 | $7.45 | $18,625.00 |
DisclosureSEC source: 0001127602-19-019143 · form4.xml · nonDerivative · entry 3 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,176 F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.41 to $7.45. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:21 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 4,750 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001127602-19-019143 · form4.xml · derivative · entry 4 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,000 Underlying: Common Stock · 4,750 shares Expires 2023-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:21 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 7,250 | $7.72 | $55,970.00 |
DisclosureSEC source: 0001127602-19-019143 · form4.xml · nonDerivative · entry 2 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,676 F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.55 to $8.03. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:21 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionCommon Stock | 4,750 | $1.42 | $6,745.00 |
DisclosureSEC source: 0001127602-19-019143 · form4.xml · nonDerivative · entry 1 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| May 15, 2019 Filed May 16, 2019 20:29 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 4,750 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001127602-19-018740 · form4.xml · derivative · entry 6 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,750 Underlying: Common Stock · 4,750 shares Expires 2023-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| May 15, 2019 Filed May 16, 2019 20:29 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 7,250 | $7.92 | $57,420.00 |
DisclosureSEC source: 0001127602-19-018740 · form4.xml · nonDerivative · entry 4 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,176 F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.71 to $8.04. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| May 15, 2019 Filed May 16, 2019 20:29 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionCommon Stock | 4,750 | $1.42 | $6,745.00 |
DisclosureSEC source: 0001127602-19-018740 · form4.xml · nonDerivative · entry 3 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:29 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001127602-19-018740 · form4.xml · derivative · entry 5 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,500 Underlying: Common Stock · 4,500 shares Expires 2023-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:29 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 4,500 | $7.62 | $34,290.00 |
DisclosureSEC source: 0001127602-19-018740 · form4.xml · nonDerivative · entry 2 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,676 F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.55 to $7.70. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:29 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionCommon Stock | 4,500 | $1.42 | $6,390.00 |
DisclosureSEC source: 0001127602-19-018740 · form4.xml · nonDerivative · entry 1 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| May 13, 2019 Filed May 13, 2019 20:57 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 9,750 | $0.00 Strike: $5.51 | $0.00 |
DisclosureSEC source: 0001127602-19-018347 · form4.xml · derivative · entry 6 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,250 Underlying: Common Stock · 9,750 shares Expires 2027-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| May 13, 2019 Filed May 13, 2019 20:57 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 9,750 | $7.76 | $75,660.00 |
DisclosureSEC source: 0001127602-19-018347 · form4.xml · nonDerivative · entry 4 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,676 F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.65 to $7.89. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| May 13, 2019 Filed May 13, 2019 20:57 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionCommon Stock | 9,750 | $5.51 | $53,722.50 |
DisclosureSEC source: 0001127602-19-018347 · form4.xml · nonDerivative · entry 3 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| May 09, 2019 Filed May 13, 2019 20:57 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 9,750 | $0.00 Strike: $5.51 | $0.00 |
DisclosureSEC source: 0001127602-19-018347 · form4.xml · derivative · entry 5 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,000 Underlying: Common Stock · 9,750 shares Expires 2027-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| May 09, 2019 Filed May 13, 2019 20:57 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 9,750 | $7.63 | $74,392.50 |
DisclosureSEC source: 0001127602-19-018347 · form4.xml · nonDerivative · entry 2 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,676 F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.51 to $7.78. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| May 09, 2019 Filed May 13, 2019 20:57 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionCommon Stock | 9,750 | $5.51 | $53,722.50 |
DisclosureSEC source: 0001127602-19-018347 · form4.xml · nonDerivative · entry 1 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| May 06, 2019 Filed May 6, 2019 20:51 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $5.51 | $0.00 |
DisclosureSEC source: 0001127602-19-017457 · form4.xml · derivative · entry 6 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,750 Underlying: Common Stock · 9,000 shares Expires 2027-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| May 06, 2019 Filed May 6, 2019 20:51 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 9,000 | $7.75 | $69,750.00 |
DisclosureSEC source: 0001127602-19-017457 · form4.xml · nonDerivative · entry 4 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,676 F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.43 to $7.86. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| May 06, 2019 Filed May 6, 2019 20:51 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionCommon Stock | 9,000 | $5.51 | $49,590.00 |
DisclosureSEC source: 0001127602-19-017457 · form4.xml · nonDerivative · entry 3 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:51 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 7,750 | $0.00 Strike: $5.51 | $0.00 |
DisclosureSEC source: 0001127602-19-017457 · form4.xml · derivative · entry 5 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,750 Underlying: Common Stock · 7,750 shares Expires 2027-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:51 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 7,750 | $7.30 | $56,575.00 |
DisclosureSEC source: 0001127602-19-017457 · form4.xml · nonDerivative · entry 2 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,676 F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.19 to $7.42. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:51 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionCommon Stock | 7,750 | $5.51 | $42,702.50 |
DisclosureSEC source: 0001127602-19-017457 · form4.xml · nonDerivative · entry 1 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 18:30 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $5.51 | $0.00 |
DisclosureSEC source: 0001127602-19-014988 · form4.xml · derivative · entry 3 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,500 Underlying: Common Stock · 7,500 shares Expires 2027-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 18:30 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 7,500 | $8.81 | $66,075.00 |
DisclosureSEC source: 0001127602-19-014988 · form4.xml · nonDerivative · entry 2 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,676 F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.80 to $8.81. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 18:30 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionCommon Stock | 7,500 | $5.51 | $41,325.00 |
DisclosureSEC source: 0001127602-19-014988 · form4.xml · nonDerivative · entry 1 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 20:18 UTC |
ASELAGE STEVEDirector
|
PurchaseCommon Stock | 2,000 | $8.30 | $16,600.00 |
DisclosureSEC source: 0001127602-19-011361 · form4.xml · nonDerivative · entry 1 ASELAGE STEVE · CIK 0001221599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.21 to $8.38. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 21:13 UTC |
Babu Yarlagadda SSenior VP - Drug Discovery
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 12,188 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001127602-19-003737 · form4.xml · derivative · entry 6 Babu Yarlagadda S · CIK 0001452635 · Senior VP - Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,188 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 21:13 UTC |
Babu Yarlagadda SSenior VP - Drug Discovery
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 19,686 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001127602-19-003737 · form4.xml · derivative · entry 5 Babu Yarlagadda S · CIK 0001452635 · Senior VP - Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,686 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 21:13 UTC |
Babu Yarlagadda SSenior VP - Drug Discovery
|
Tax withholdingCommon Stock | 1,685 | $8.68 | $14,625.80 |
DisclosureSEC source: 0001127602-19-003737 · form4.xml · nonDerivative · entry 4 Babu Yarlagadda S · CIK 0001452635 · Senior VP - Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,587 F2 · security: Shares of Common Stock delivered to the Company to satisfy payment of exercise price in connection with stock option exercise. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 21:13 UTC |
Babu Yarlagadda SSenior VP - Drug Discovery
|
Exercise / conversionCommon Stock | 12,188 | $1.20 | $14,625.60 |
DisclosureSEC source: 0001127602-19-003737 · form4.xml · nonDerivative · entry 3 Babu Yarlagadda S · CIK 0001452635 · Senior VP - Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,272 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 21:13 UTC |
Babu Yarlagadda SSenior VP - Drug Discovery
|
Tax withholdingCommon Stock | 7,702 | $8.68 | $66,853.36 |
DisclosureSEC source: 0001127602-19-003737 · form4.xml · nonDerivative · entry 2 Babu Yarlagadda S · CIK 0001452635 · Senior VP - Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,084 F1 · security: Shares of Common Stock delivered to the Company to satisfy payment of exercise price and tax withholding in connection with stock option exercise. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 21:13 UTC |
Babu Yarlagadda SSenior VP - Drug Discovery
|
Exercise / conversionCommon Stock | 19,686 | $1.20 | $23,623.20 |
DisclosureSEC source: 0001127602-19-003737 · form4.xml · nonDerivative · entry 1 Babu Yarlagadda S · CIK 0001452635 · Senior VP - Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2019 Filed Jan 29, 2019 21:21 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001127602-19-002873 · form4.xml · derivative · entry 9 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,427 Underlying: Common Stock · 2,000 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2018. Read SEC document |
| January 28, 2019 Filed Jan 29, 2019 21:21 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001127602-19-002873 · form4.xml · derivative · entry 8 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,427 Underlying: Common Stock · 4,000 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 28, 2019 Filed Jan 29, 2019 21:21 UTC |
Powell LynneSenior VP - CCO
|
SaleCommon Stock | 2,000 | $9.91 | $19,820.00 |
DisclosureSEC source: 0001127602-19-002873 · form4.xml · nonDerivative · entry 6 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2018. F5 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.90 to $9.91. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| January 28, 2019 Filed Jan 29, 2019 21:21 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionCommon Stock | 2,000 | $3.22 | $6,440.00 |
DisclosureSEC source: 0001127602-19-002873 · form4.xml · nonDerivative · entry 5 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2018. Read SEC document |
| January 28, 2019 Filed Jan 29, 2019 21:21 UTC |
Powell LynneSenior VP - CCO
|
SaleCommon Stock | 4,000 | $9.88 | $39,520.00 |
DisclosureSEC source: 0001127602-19-002873 · form4.xml · nonDerivative · entry 4 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. F3 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.85 to $9.91. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| January 28, 2019 Filed Jan 29, 2019 21:21 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionCommon Stock | 4,000 | $3.22 | $12,880.00 |
DisclosureSEC source: 0001127602-19-002873 · form4.xml · nonDerivative · entry 3 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 21:10 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001127602-19-003053 · form4.xml · derivative · entry 3 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 5,000 shares Expires 2023-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2018. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 21:10 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 5,000 | $9.85 | $49,250.00 |
DisclosureSEC source: 0001127602-19-003053 · form4.xml · nonDerivative · entry 2 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,426 F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2018. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 21:10 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionCommon Stock | 5,000 | $5.45 | $27,250.00 |
DisclosureSEC source: 0001127602-19-003053 · form4.xml · nonDerivative · entry 1 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2018. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 21:21 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001127602-19-002873 · form4.xml · derivative · entry 7 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,427 Underlying: Common Stock · 6,000 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 21:21 UTC |
Powell LynneSenior VP - CCO
|
SaleCommon Stock | 6,000 | $9.60 | $57,600.00 |
DisclosureSEC source: 0001127602-19-002873 · form4.xml · nonDerivative · entry 2 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.50 to $9.71. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 21:21 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionCommon Stock | 6,000 | $3.22 | $19,320.00 |
DisclosureSEC source: 0001127602-19-002873 · form4.xml · nonDerivative · entry 1 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:12 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001127602-19-002527 · form4.xml · derivative · entry 3 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,427 Underlying: Common Stock · 2,000 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.